4th Rare & Genetic Kidney Disease Drug Development Summit

Published on 05/12/2024

10-12 December 2024
Boston, MA, USA

ENYO Pharma will attend for the first time the 4th Rare & Genetic Kidney Disease Drug Development Summit that will be held in Boston, USA. The event will bring together industries, academic KOLs, and patient advocacy nephrology communities to discuss acceleration of clinical advancements in orphan kidney disease populations.
ENYO Pharma will present the ongoing ALPESTRIA-1 Phase 2 clinical trial with Vonafexor in patients with Alport syndrome.

https://rare-kidney-drug-development.com/

Read next in 'Events'

• J.P. Morgan week and WuXi Global Forum 2025 in San Francisco
• J.P. Morgan week et WuXi Global Forum 2025 à San Francisco
• 4th Rare & Genetic Kidney Disease Drug Development Summit
• MOSAIC - Global NASH Trialist Forum 2024
• MOSAIC - the Global NASH/MASH Trialist Forum